Related references
Note: Only part of the references are listed.Amyloidogenic and non-amyloidogenic transthyretin variants interact differently with human cardiomyocytes: insights into early events of non-fibrillar tissue damage
Pallavi Manral et al.
BIOSCIENCE REPORTS (2015)
A unified framework based on the binding polynomial for characterizing biological systems by isothermal titration calorimetry
Sonia Vega et al.
METHODS (2015)
Quantification of Quaternary Structure Stability in Aggregation-Prone Proteins under Physiological Conditions: The Transthyretin Case
Lei Z. Robinson et al.
BIOCHEMISTRY (2014)
Age-Related Oxidative Modifications of Transthyretin Modulate Its Amyloidogenicity
Lei Zhao et al.
BIOCHEMISTRY (2013)
Effect on disability and safety of Tafamidis in late onset of Met30 transthyretin familial amyloid polyneuropathy
P. Lozeron et al.
EUROPEAN JOURNAL OF NEUROLOGY (2013)
Repurposing Diflunisal for Familial Amyloid Polyneuropathy A Randomized Clinical Trial
John L. Berk et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
TAFAMIDIS FOR TRANSTHYRETIN FAMILIAL AMYLOID POLYNEUROPATHY: A RANDOMIZED, CONTROLLED TRIAL
Ingemar S. J. Merkies
NEUROLOGY (2013)
AG10 inhibits amyloidogenesis and cellular toxicity of the familial amyloid cardiomyopathy-associated V122I transthyretin
Sravan C. Penchala et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
The Transthyretin Amyloidoses: From Delineating the Molecular Mechanism of Aggregation Linked to Pathology to a Regulatory-Agency-Approved Drug
Steven M. Johnson et al.
JOURNAL OF MOLECULAR BIOLOGY (2012)
Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade
Christine E. Bulawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Mechanisms of transthyretin cardiomyocyte toxicity inhibition by resveratrol analogs
Steve Bourgault et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Dissecting the Structure, Thermodynamic Stability, and Aggregation Properties of the A25T Transthyretin (A25T-TTR) Variant Involved in Leptomeningeal Amyloidosis: Identifying Protein Partners That Co-Aggregate during A25T-TTR Fibrillogenesis in Cerebrospinal Fluid
Estefania P. C. Azevedo et al.
BIOCHEMISTRY (2011)
Natural polyphenols inhibit different steps of the process of transthyretin (TTR) amyloid fibril formation
Nelson Ferreira et al.
FEBS LETTERS (2011)
Transthyretin-related amyloidoses and the heart: a clinical overview
Claudio Rapezzi et al.
NATURE REVIEWS CARDIOLOGY (2010)
Binding of epigallocatechin-3-gallate to transthyretin modulates its amyloidogenicity
Nelson Ferreira et al.
FEBS LETTERS (2009)
Identification of metabolite profiles of the catechol-O-methyl transferase inhibitor tolcapone in rat urine using LC/MS-based metabonomics analysis
Jinchun Sun et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2009)
Do enthalpy and entropy distinguish first in class from best in class?
Ernesto Freire
DRUG DISCOVERY TODAY (2008)
Biochemical and structural evaluation of highly selective 2-arylbenzoxazole-based transthyretin amyloidogenesis inhibitors
Steven M. Johnson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Toward Optimization of the Linker Substructure Common to Transthyretin Amyloidogenesis Inhibitors Using Biochemical and Structural Studies
Steven M. Johnson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Comparative in vitro and ex vivo activities of selected inhibitors of transthyretin aggregation:: relevance in drug design
Isabel Cardoso et al.
BIOCHEMICAL JOURNAL (2007)
Transthyretin and familial amyloidotic polyneuropathy - Recent progress in understanding the molecular mechanism of neurodegeneration
Xu Hou et al.
FEBS JOURNAL (2007)
Diflunisal stabilizes familial amyloid polyneuropathy-associated transthyretin variant tetramers in serum against dissociation required for amyloidogenesis
Kana Tojo et al.
NEUROSCIENCE RESEARCH (2006)
Orally administered diflunisal stabilizes transthyretin against dissociation required for amyloidogenesis
Yoshiki Sekijima et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2006)
Native state kinetic stabilization as a strategy to ameliorate protein misfolding diseases: A focus on the transthyretin amyloidoses
SM Johnson et al.
ACCOUNTS OF CHEMICAL RESEARCH (2005)
Novel cell lines derived from adult human ventricular cardiomyocytes
MM Davidson et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2005)
Kinetic stabilization of an oligomeric protein by a single ligand binding event
RL Wiseman et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2005)
The biological and chemical basis for tissue-selective amyloid disease
Y Sekijima et al.
CELL (2005)
Kinetic assay for high-throughput screening of in vitro transthyretin amyloid fibrillogenesis inhibitors
I Dolado et al.
JOURNAL OF COMBINATORIAL CHEMISTRY (2005)
Design, synthesis, and evaluation of oxazole transthyretin amyloidogenesis inhibitors
H Razavi et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Tissue damage in the amyloidoses: Transthyretin monomers and nonnative oligomers are the major cytotoxic species in tissue culture
N Reixach et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Ten years of international experience with liver transplantation for familial amyloidotic polyneuropathy: Results from the familial amyloidotic polyneuropathy world transplant registry
G Herlenius et al.
TRANSPLANTATION (2004)
Diflunisal analogues stabilize the native state of transthyretin. Potent inhibition of amyloidogenesis
SL Adamski-Werner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Selective binding to transthyretin and tetramer stabilization in serum from patients with familial amyloidotic polyneuropathy by an iodinated diflunisal derivative
MR Almeida et al.
BIOCHEMICAL JOURNAL (2004)
Transthyretin aggregation under partially denaturing conditions is a downhill polymerization
AR Hurshman et al.
BIOCHEMISTRY (2004)
Native state stabilization by NSAIDs inhibits transthyretin amyloidogenesis from the most common familial disease variants
SR Miller et al.
LABORATORY INVESTIGATION (2004)
4′-iodo-4′-Deoxydoxorubicin and tetracyclines disrupt transthyretin amyloid fibrils in vitro producing noncytotoxic species:: screening for TTR fibril disrupters
I Cardoso et al.
FASEB JOURNAL (2003)
Energetic characteristics of the new transthyretin variant A25T may explain its atypical central nervous system pathology
Y Sekijima et al.
LABORATORY INVESTIGATION (2003)
Sequence-dependent denaturation energetics:: A major determinant in amyloid disease diversity
P Hammarström et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases
M Bucciantini et al.
NATURE (2002)
Synthesis, structure, and activity of diclofenac analogues as transthyretin amyloid fibril formation inhibitors
VB Oza et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
The V122I cardiomyopathy variant of transthyretin increases the velocity of rate-limiting tetramer dissociation, resulting in accelerated amyloidosis
X Jiang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Pathogenesis of NSAID-induced gastroduodenal mucosal injury
JL Wallace
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2001)
An engineered transthyretin monomer that is nonamyloidogenic, unless it is partially denatured
X Jiang et al.
BIOCHEMISTRY (2001)
Transthyretin: a review from a structural perspective
JA Hamilton et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2001)
Tetramer dissociation and monomer partial unfolding precedes protofibril formation in amyloidogenic transthyretin variants
A Quintas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
A comparative analysis of 23 structures of the amyloidogenic protein transthyretin
A Hörnberg et al.
JOURNAL OF MOLECULAR BIOLOGY (2000)
Consumption of NSAIDs and the development of congestive heart failure in elderly patients -: An underrecognized public health problem
J Page et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
Share Paper
